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Summary
We have createdJ chain knockout mice to define the physiologic role of theJ chain in immuno-
globulin synthesis and transport. The J chain is covalently associated with pentameric immunoglo-
bulin (Ig) M and dimeric IgA and is also expressed in most IgG-secreting cells. J chain-defi-
cient mice have normal serum IgM and IgG levels but markedly elevated serum IgA. Although
polymeric IgA was present in the mutant mice, a larger proportion of their serum IgA was mo-
nomeric than was found in wild-type mouse serum. Bile and fecal IgA levels were decreased in
J chain-deficient mice compared with wild-type mice, suggesting inefficient transport of J
chain-deficient IgA by hepatic polymeric immunoglobulin receptors (pIgR) . The pIgR-medi-
ated transport of serum-derived IgA from wild-type and mutant mice was assessed in Madin-
Darby canine kidney (MDCK) cells transfected with the pIgR. These studies revealed selective
transport by pIgR-expressing MDCK cells ofwild-type IgA but notj chain-deficient IgA. We
conclude that although the J chain is not required for IgA dimerization, it does affect the effi-
ciency of polymerization or have a role in maintaining IgA dimer stability. Furthermore, the J
chain is essential for efficient hepatic pIgR transport of IgA.
T
he J chain is a 15-kD glycoprotein covalently linked
by disulfide bonds with polymeric IgA (pIgR) and
IgM, implicating this glycoprotein in the polymerization
process (1) . The role of the J chain in polymer formation
and stabilization, however, remains uncertain (2) . The J
chain is also expressed in many IgG-secreting cells, al-
though its function in these cells is unknown (1, 3, 4) .
Some studies have suggested that the J chain plays a role in
polymeric Ig receptor (pIgR)-mediated transport of IgA
(5-7), while other studies have questioned the J chain's sig-
All animal care wasin accordance with insititutional guidelines. For inva-
sive procedures, mice were anesthetized with Avertin (0.017 ml/g) i.p.
before the procedure.
'Abbreviations used in thispaper: DTT, dithiothreitol; ES, embryonic stem;
FIAU, fialuridine; Jch, J chain mutation; MDCK, Madin-Darby canine
kidney; neon, neomycin resistance gene; plgA, polymeric IgA; pIgR,
polymeric Ig receptor; SC, secretory component.
nificance in this process (8, 9) . The hepatic pIgR transports
pIgA out of the serum into the bile (10-13). In mice and
rats, which express pIgR on their hepatocytes, hepatic
transport of IgA into bile plays an important role in serum
IgA clearance (10-15) . Knowledge of the mechanism and
regulation of secretory IgA transport is important to our
understanding of host defenses against mucosally acquired
pathogens and of the liver's role in clearing IgA-antigen
complexes from the circulation.
Knockout mice lacking the J chain provide an excellent
tool for defining the role of this polypeptide in Ig synthesis
and transport. Most of the previous work investigating the
function of the J chain in these processes has been done
with purified preparations of Ig andJ chain or with isolated
cell lines. Using j chain-deficient mice created using gene
targeting techniques, we demonstrate here that IgA dimer-
ization can occur in vivo in the absence of the J chain.
However, the J chain is required for the efficient transport
ofserum-derived IgA into bile.
1905
￿
J. Exp. Med. C The Rockefeller University Press " 0022-1007/95/12/1905/07 $2.00
Volume 182 December 1995 1905-1911Materials and Methods
Preparation of Targeting Construct.
￿
The J chain gene isolated
from a WEHI231.R lymphoma library in Charon 4A was kindly
provided by Dr, M. Koshland (Department of Molecular and
Cell Biology, University of California, Berkeley, CA). The neo-
rnycin resistance gene (neo') under the control of the phospho-
glycerate kinase promoter was cloned into an Ava I site ofa Pstl-
Ncol 9.3-kb genomic fragment containing the entire murine J
chain gene subdoned in Bluescript SK 11' (Stratagene Inc., La
Jolla, CA). The phosphoglycerate kinase-Herpes simplex thymi-
dine kinase gene was cloned into a Sall site in the polylinker.
ES Cell Transfection and Culture.
￿
The male embryonic stem
(ES) cell line Cl, (derived from mouse strain 129/SvJ by D. A.
Connor), was cultured on irradiated mouse embryonic fibroblasts
in supplemented DME with 500 U/ml LIF (Gibco Laboratories,
Grand Island, NY). Construct DNA (16 Rg) was transfected by
electroporation (125 p,F, 450 V; Gene Pulser; Bio-RadLaborato-
ries, Hercules, CA) into 2 X 10' C1 ES cells. Cells surviving
G418 (230 wg/ml, Gibco Laboratories) and fialuridine (FIAU)
(0.2 wM; Bristol Meyers Squib, Wallingford, CT), added 1 and 2
d after electroporation, respectively, were screened by Southern
blot analysis as described previously (16) with a BamHI-Sstl frag-
ment shown in Fig. 1 A.
Northern Blot Analyses. RNA harvested from splenocytes
stimulated with LPS (50 Rg/ml; L-7261 Sigma Chemical Co., St.
Louis, MO) and IL-5 (25 U/ml; Genzyme Corp., Cambridge,
MA) was fractionated on a formaldehyde-agarose (1%) gel, trans-
ferred to GeneScreen (NEN Research Products, Boston, MA),
hybridized with 12P-labeled 1.1-kb BamHI-EcoRIJ chain cDNA
(a kind gift of Dr. M. Koshland) and murine actin probes, and
washed as described previously (16).
Rabbit Anti-Humanj Chain Antiserum.
￿
RecombinantJ chain
was synthesized and purified in Escherichia coli strain M15 (Qiagen,
Chatsworth, CA) carrying an expression plasmid expressing the
human J chain cDNA. Total RNA was prepared from human
Dakiki cells (TIB 206; American Type Culture Collection,
Rockville, MD) as described (17) . Human J chain cDNA encod-
ing the mature protein (i.e., exons 2-4, omitting the signal pep-
tide) was obtained by reverse transcription-PCR using primer 5'-
GCC AAG CTT TTA GTC AGG ATA GC-3' for reverse
transcription and subsequent PCR amplification, together with
primer 5'-GGA GAT CTG AAG ATG AAA GG-3'. Primers
were designed based on the published genomic sequence (18).
Underlined sequences represent additional nucleotides corre-
sponding to restriction sites HindIII and Bg1II that were used for
subsequent cloning into the pQE9 (Qiagen) bacterial expression
vector. Plasmid bearing E. coli were induced with 0.5 mM iso-
propyl-(3-D-thiogalactopyranoside (IPTG; Sigma Chemical Co.) .
3 h after induction, the protein was recovered from inclusion
bodies, solubilized in 7 M urea, and purified by affinity chroma-
tography on Ni2+-chelate agarose beads. A 3-mo-old female
New Zealand rabbit was primed with 200 FLg of recombinant J
chainin urea by subcutaneous injection and subsequently boosted
monthly with the same amount ofJ chain.
Immunoglobulin ELISAs.
￿
IgA and IgG ELISAs were per-
formed as described previously (19). For the IgM ELISAs, diluted
samples were added to immunoplates (MaxiSorp; Nunc, Rosk-
ilde, Denmark) coated with 5 Wg/ml goat anti-mouse IgM (Cap-
pel Research Products, Durham, NC) in bicarbonate buffer and
blocked with 3% BSA. IgM was detected with rabbit anti-mouse
IgM alkaline phosphatase conjugate (Zymed Laboratories, Inc.,
South San Francisco, CA)/1 mg/mlp-nitropheryl phosphate (Sigma
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Chemical Co.) . Absorbance readings were compared with stan-
dard curves generated with IgM (PharMingen, San Diego, CA).
Protein Electrophoresis and Immunostainingfor IgA. For native
gels, samples were diluted in Tris/HCl buffer (pH 8.9) and elec-
trophoresed on 10% polyacrylamide gels (CleanGel; Pharmacia
Biotech, Piscataway, NJ). For denaturing gels, samples were di-
luted in SDS sample buffer without reducing agent, heated to
100°C for 1 min to avoid breakdown of polymers, and electro-
phoresed on 7.5% polyacrylamide gels (ExcelGel; PharmaciaBio-
tech). Proteins were transferred to nitrocellulose (Hybond ECL;
Amersham Corp., Arlington Heights, IL), immunostained with
rabbit anti-mouse a chain (Zymed Laboratories, Inc.) and de-
tected with the ECL chemiluminescent system with horseradish
peroxidase-conjugated secondary antiserum (Amersham Corp.).
Secretory IgA Collections. Freshly voided fecal samples were
vacuum dried and extracted in PBS with 5% nonfat dry milk and
protease inhibitors. Bile was aspirated from dilated gall bladders
24 h after bile duct ligation.
In Vitro pIgR-transfected Madin-Darby Canine Kidney Cell Experi-
ments. Wild-type Madin-Darby canine kidney (MDCK) strain
Il cells or MDCK Strain II cells expressing the rabbit pIgR (20)
were maintained in DME containing 10% fetal bovine serum and
antibiotics. For transcytosis assays, cells were plated at confluent
density onto 12-mm filter chambers (0.4-1im pore Transwells;
Costar Corp., Cambridge, MA) and cultured for 4 d before use.
Filters were then washed twice in serum-free DME and placed
into 12-well plates containing 500 p,l/well DME supplemented
with serum (10%) from either wild-type or J chain-deficient
mice . An equal volume of serum-free medium was added to the
upper buffer chamber. The cultures were then incubatedfor72 h
at 37°C in 5% COz, after which samples ofboth apical and baso-
lateral medium were removed from the filter chambers andstored
at -20°C until IgA and IgG levels were measured by ELISA.
Results
Thej Chain Gene Was Inactivated by Homologous Recombi-
nation in ES Cells. To inactivate the J chain gene in ES
cells, a targeting vector was constructed using a 9.3-kb
fragment encoding the entire murine J chain gene (Fig. 1
A). The gene was interrupted in exon 2, the first coding
exon of the mature protein, by the neon. In addition, the
Herpes simplex thymidine kinase gene was placed outside
the region of homology to allow negative selection against
random integration events. The linearized targeting con-
struct was then introduced by electroporation into C1 cells,
a 129/SvJ ES cell line (D. A. Connor, unpublished data).
ES cells surviving G418, a neomycin analogue, and FIAU
selection were screened for insertions in theJ chain gene by
Southern blot analysis using an external 5'J chain genomic
probe. ES cells containing the mutatedJ chain gene exhib-
ited a novel 4.8-kb BamHI fragment due to the introduced
neon sequences. Three independent targeted clones were
identified among 51 neo' FIAU' clones analyzed. Cells
from these three clones were then injected into C57B1/6
blastocysts. One of these injected clones yielded four germ-
line chimeric males. Heterozygous offspring of founder
males were bred to produce mice homozygous for the J
chain mutation (Jch-l-). Mice heterozygous (Jch+l-) and
Altered Hepatic Transport of IgA in Mice Lacking theJ Chainhomozygous for the J chain mutation were characterized
by Southern blot analyses of tailDNA (Fig . 1 B) .
To confirm that Jch-1- mice lacked the ability to express
the J chain, Northern blot analyses ofRNA from Jch-'-
and wild-type (Jch+'+) spleen cells were performed . Jch+"
mouse-derived splenocytes had easily detectable 1.3-kb J
chain mRNA, whereas no J chain message was noted in
splenocytes from the Jch-'- mice despite overloading the
lane as judged by ethidium bromide staining and actin
probe hybridization (Fig . 1 C . The inability of Jch-'-
mice to produceJ chain proteinwas documented by Western
blot analysis using an anti-human J chain Ab that cross-
reacts with mouseJ chain . J chainprotein was easily visual-
ized in IgAhybridoma P1 E10 supernatant and in the serum
of Jch+1+ mice . However, no J chain protein was detect-
able in the serum ofJch- '- mice (Fig . 1 D) .
J Chain-deficient Mice Have Elevated Serum IgA Levels .
Jch- '- mice, maintained in avirus-free animal facility, have
been observed through 12 mo of age and appear healthy
and grossly normal compared with their wild-type litter-
mates . FRCS® analysis of splenocytes fromJch-1- mice us-
ing mAbs to N, chain, B220, CD3, CD4, CD8, and synde-
can-1 (21), a murine plasma cell marker, revealed staining
patterns indistinguishable from Jch"+ littermates (data not
shown) .
Serum immunoglobulin levels were examined byELISA
in 6-10-wk-oldJch+'+ and Jch-1- mice . Measurement of
serum IgM andIgG levels in 14 mice (7 Jch+" and7Jch-~-)
revealed no significant differences between Jch+ 1+ and
Jch-1- animals (Table 1) . In contrast, serum IgA levels in
Jch-'- mice were >30 times greater than inJch"+ mice
(Table 1) .
1907
￿
Hendrickson et al .
Values listed are the mean ± SD (n = 7) reported in micrograms per
milliliter .
The IgA Dimer:Monomer Ratio Is Altered in Jch-1- Serum .
To distinguish between monomeric and dimeric IgA, sera
fromJch"+ andJch- '- mice were fractionated by PAGE .
Serum samples were electrophoresed under both nondena-
turing and denaturing conditions . IgA was detected by
Western blotting with an anti-mouse ot-chain Ab (Fig . 2) .
As predicted by the ELISA, dramatically more IgA was
found in Jch-1- serum than Jch+'+ serum . Monomeric,
dimeric, and higher polymeric forms of IgA present in
Jch"+ serum were also detected in Jch-'- serum (Fig. 2
A) . Heating to 100°C for 4 min in the presence of dithio-
threitol (DTT) reduced the dimeric forms to their compo-
nent heavy chains (data not shown) . Whereas the dimer/
monomer ratio was, as previously reported (14), -1 :1 in
wild-type mice, Jch-1- mice had at least 10 times more
monomer than dimer by quantitative densitometry (Fig . 2
A and data not shown) . Nonetheless, because of the ele-
vated levels of serum IgA in the Jch- '- mice, the absolute
amounts of dimer present in Jch-'- serum appeared com-
parable to if not somewhat greater than that in Jch"+
Figure 1 .
￿
Disruption of the J chain gene by
homologous recombination . (A) J chain gene
targeting construct. A, Ava I ; Bt, BstE2 ; E,
EcoRI ; N, NcoI; P, Pstl . (B) Southern blot
analysis ofBamHI-digested tail DNA from off-
spring ofa mating oftwo heterozygotes derived
from a germline transmitting male chimera. Us-
ing the probe shown in A, mice with both J
chain alleles disrupted exhibited only a 4.8-kb
band, whereas wild-type animals exhibited a
3.0-kb band . Representative Jch"+, Jch+ ~- ,
and Jch-'- mice are shown. (C Northern blot
analysis using J chain cDNA and murine actin
probes of splenocyte RNA from Jch+/+ and
Jch- /- mice . (D) Western blot analysis ofJch+i+
and Jch-/- serum and supernatant from an IgA
hybridoma cell line Pl E10, used as a control.
Serum samples were diluted 1 :100 in sample
buffer containing DTT, fractionated by SDS-
PAGE on a 15% gel and immunoblotted with
anti-human J chain Ab . The blot on the right
shows the same two Jch+/+ and Jch- ' - lanes
probed with an anti-tx chain Ab .
Table 1,
Ig
Serum Ig Levels
Jch+ 1+
in Jch+1+ andJch - ' -
Jch-1-
Mice
Significance
IgM 174± 56 148 ± 47 NS
IgG 1,132 ± 565 1,021 ± 338 NS
IgA 90 ± 53 2,929 ± 2,027 p = 0.003mouse serum . We suggest that although IgA is able to
dimerize in the absence of J chain, either dimerization is
less efficient or J chain-deficient dimers are less stable than
normal dimeric IgA.
J Chain-deficient IgA Is Not Transported Efficiently into Bile .
To examine the ability ofJch- '- mice to secrete IgA into
bile, we measured IgA levels in bile aspirated from dilated
gall bladders 24 h after bile duct ligation . In addition, we
measured fecal IgA levels, which are derived, at least in
part, from bile . IgA levels in bile were 3 .5 times lower in
the Jch- '- mice than Jch"+ mice (Table 2) . In addition,
fecal IgA levels were profoundly decreased in Jch- '- mice
(Table 2) . Thus, these findings-elevated serum IgA with a
corresponding decrease in bile and fecal IgA-suggested
that Jch- ' - mice have a defect in the hepatic transport of
bloodstream-derived IgA into bile .
Jch-- Bile Contains Nondimeric Forms of IgA Not Seen in
Jch"+ Bile. Samples of serum and bile from Jch-- and
Jch"+ mice were then electrophoresed on nonreducing,
SDS-containing gels and the transferred proteins were de-
tected with an anti-mouse ot-chain Ab . Although nearly all
of the IgA present in Jch"+ bile was dimeric, studies of
Table 2 .
￿
IgA Levels Found at Different Sites inJch"+ and
jch-- Mice
IgA levels are reported in micrograms per milliliter except those offecal
samples, which are micrograms per gram. Values listed are the mean ±
SD (n = 3), except for the bile ofJch-- mice (n = 4) .
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Jch - '- bile-derived IgA revealed very small amounts of
dimer and prominent lower molecular weight bands (Fig. 2
B) . The composition of these IgA-immunoreactive lower
molecular weight bands is not yet defined .
Jch-- Serum-derived IgA Is Not Selectively Transported by
pIgR in an In Vitro System . The hepatic pIgR transports
serum-derived pIgR into bile (10-13) . pIgR binds to the
pIgR and is transported as a complex to the bile-canalicular
surface, where the receptor is proteolytically cleaved, with
a portion known as secretory component (SC) remaining
associated with the pIg in bile . We hypothesized that the
inefficient hepatic transport of IgA in Jch-- mice was due
to an inability of these receptors to transport J chain-defi-
cient IgA . To examine the capability of the pIgR to trans-
port J chain-deficient IgA, we used MDCK cells stably
transferred with the pIgR cDNA to study transport of
Jch" + mouse-derived IgA versus Jch-1- mouse-derived
IgA . Equivalent volumes ofJch"+ or Jch-- serum were
added to the basolateral surfaces of polarized monolayers of
MDCK cells (wild-type or pIgR-expressing) grown on
membranes in two-chambered vessels . After 72 h, superna-
tants from the apical chambers, which contained IgA trans-
ported across the MDCK monolayers, and supernatants
from the basal chambers were collected . Supernatant levels
of IgG, which is not transported by the pIgR, and IgA
were then measured by ELISA (Fig. 3 A) . As expected,
Jch"+ mouse-derived IgA was selectively transported by
the pIgR-expressing (pIgR+) cells, with apical chamber
IgA levels 22-fold higher than the apical chamber IgA lev-
els ofMDCK cells not expressing pIgR (plgR- ) . In con-
trast, similar amounts ofJch-- mouse-derived IgA were
noted in the apical chambers ofpIgR- and pIgR+ MDCK
cells . In addition, the fraction ofJch-- mouse-derived
IgA transported by the pIgR+ cells was similar to that of
IgG transported by both pIgR+ and pIgR- cells (Fig . 3 B) .
Addition ofJch-- serum to basal chambers containing
Jch" + serum did not appear to inhibit transport ofJch+1+
Altered Hepatic Transport ofIgA in Mice Lacking the J Chain
Figure 2 .
￿
IgA in serum and bile samples from
Jch+'+ and Jch- '- mice immunostained with
anti-mouse a-chain Ab . (A) Serum diluted 1:100
electrophoresed under nondenaturing, nonre-
ducing conditions. Monomeric, dimeric, and
higher polymer bands are seen . IgA hybridoina
P1 E10 supernatant, which consists primarily of
dimers and higher polymers, is included as a
control . 20- and 1-nun exposures of the Jch-''
and Jch+" lanes are shown . Monomer (Al) and
dimer (D) bands are indicated . (B) Representa-
tive serum diluted 1:100 and bile diluted 1 :2
electrophoresed under nonreducing conditions
in the presence of SDS . Molecular mass markers
in kilodaltons are shown at left.
Site Jch+/+ Jch-- Significance
Serum 137 ~- 49 4,852 ± 1,580 p <0.01
Feces 564 ± 286 11 ± 9 p <0.05
Bile 212 - 130 62 ± 5 p <0.05A
B
pIgR - + - +
Jch +/+ +/+ -/- -/-
Figure 3 .
￿
Ratio of apical to basal chamber levels of IgA (A) and IgG
(B) collected 72 h after addition ofJch+/+ orJch-1- serum to either non-
expressing (pIgR- ) or expressing (pIgR+) MDCK cells . Values graphed are
the mean ±' SD (n = 3) from a representative experiment. SD for all but
the IgA ratios for Jch+/+ serum added to pIgR+ cells are too small to
show on graph .
mouse-derived IgA by the pIgR+ MDCK cells (data not
shown) .
The pIgR binds dimeric IgA but not monomeric IgA (2,
7) . Consequently, we examined the structure of the Jch+'+
mouse-derived IgA and Jch-1- mouse-derived IgA trans-
ported by the pIgR+ MDCK cells by fractionating apical
chamber samples on nonreducing, SDS-containing gels and
immunostaining with an anti-IgA Ab . Although nearly all
of the Jch+'+ mouse-derived IgA transported by pIgR+
cells was dimeric, Jch-1- mouse-derived IgA in the apical
chambers of pIgR+ cells consisted primarily of nonpoly-
meric forms (Fig . 4) . pIgA was still detectable at 72 h in
basal chambers to which Jch- '- serum had been added
(data not shown) . The data above strongly suggested that
the Jch-'- mouse-derived IgA was transported in these ex-
periments by a nonreceptor-mediated transport mecha-
nism, such as fluid phase transcytosis .
Discussion
We conclude that the J chain is not required for the se-
cretion of IgM or dimeric IgA by B lymphocytes in vivo .
However, our data indicate that although IgA dimers are
produced in the absence of the J chain, either dimerization
is less efficient or the J chain-deficient dimers are less stable
than normal pIgA . We also conclude that the hepatic pIgR
clearance ofbloodstream IgA is impaired in Jch- ' - mice .
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Figure 4 . Structure of apical
chamber Jch+l+ and Jch-1- mouse-
derived IgA transported by pIgR+
MDCK cells . IgA hybridoma P1
E10 supernatant is included as a con-
trol . Representative samples of apical
chamber media concentrated with
microconcentrators (Microcon-30 ;
Amicon Inc ., Beverly, MA) were
fractionated under nonreducing
conditions in the presence of SDS
and immunostained with an anti-a
chain Ab . As noted with other IgA
dimer-rabbit SC interactions (32),
Jch"+ mouse-derived IgA dimers
appear to associate with rabbit SC by
predominantly noncovalent interac-
tions, which disassociate in SDS.
Monomer (" and dimer (D) bands
are indicated . Molecular mass mark-
ers in kilodaltons are shown at left.
The J chain is expressed in nearly all pIgA-producing
cells in secretory glands and tissues, implying a physiologic
importance in these cells (1, 2, 7) . However, the J chain's
role in IgA polymerization has remained ill defined . Previ-
ous work indicated that polymerization of IgA from its re-
duced subunits required the presence of the J chain (22,
23) . In addition, Ma et al . (24) recently described trans-
genic plants expressing a hybrid immunoglobulin A-G
heavy chain that appeared to require the J chain for dimer-
ization. By contrast, human IgA myeloma proteins that
lack the J chain or contain less than one J chain per poly-
mer have been reported (5, 6, 8) . Western blot analysis of
serum from Jch- '- mice revealed high molecular weight
IgA-immunoreactive bands migrating similar to IgA dimers
in Jch+'+ serum . Similar to wild-type IgA dimers, these
high molecular weight forms reduced in the presence of
DTT to their component heavy chains . However, whether
these J chain-deficient dimers are correctly assembled, in-
cluding in regard to their disulfide bonds, is not yet de-
fined .
Our data suggest that the J chain is not necessary for
dimer formation but is required for the normal IgA dimer/
monomer ratio found in mouse serum . One possibility is
that the addition of the J chain to dimeric IgA contributes
significantly to the stability of the intermolecular disulfide
bonds or important noncovalent interactions . The J chain's
contribution to the stability of the dimeric structure may
influence the efficiency of the polymerization process or
promote dimer stability after secretion from the B cell . The
J chain may also influence the stability of IgA in secretions .
Bile samples from Jch-1- mice have lower molecular
weight IgA-immunoreactive bands not seen inJch"+ bile
samples . The composition of these IgA-immunoreactive
lower molecular weight bands remains to be determined.
These bands may represent serum-derived dimer break-down products or possibly monomeric IgA bound to other
bile proteins. Depolymerization ofpIgR aftertransport into
bile also may account for some of the lower molecular
weight forms, including monomer, seen in the bile in Jch-1-
mice. Also monomeric IgA is believed to be more suscepti-
ble than SC-associated dimeric IgA to degradation in the
intestinal tract (25). The J chain-deficient dimer may also
be more susceptible to degradation in the intestinal tract,
contributing to the very low fecal IgA levels found in Jch-1-
mice.
Previous studies have demonstrated the importance of
hepatic clearance ofIgA in maintaining serum IgA homeo-
stasis in rodents (10-15) . For example, ligation o£ the bile
duct in mice and rats is known to cause elevations in serum
IgA (10, 14) . Hepatic transport of IgA into bile may be an
important mechanism for delivering IgA into the intestinal
tract in rodents (15). This pathway is less relevant in hu-
mans, where the vast majority of intestinal IgA is produced
in the submucosa and directly transported across the over-
lying intestinal epithelium. Transport of IgA into bile oc-
curs in humans to a much lesser degree owing to restriction
ofpIgR expression to biliary duct epithelial cells (15). Al-
though the elevated serum IgA levels found in Jch-'- mice
could theoretically result from increased IgA production,
we hypothesized that inefficient hepatic transport of J
chain-deficient IgA accounted for this finding. The de-
pleted bile and fecal IgA levels in Jch-'- mice compared
with Jch+" mice are consistent with this hypothesis.
The major receptor responsible for IgA transport into
bile and mucosal secretions is the pIgR (2, 7, 10-13). The J
chain's role in the binding of pIgR to the pIgR is unclear
(2, 26) . Brandtzaeg and Prydz (5, 6) reported that the abil-
ity of pIgR to bind to pIgR+ epithelial cells, and SC was
related to J chain content. However, Tomasi and Czerwin-
ski (8) described pIgR myeloma proteins that appeared to
lack the J chain but formed complexes with SC in vitro.
Several studies have indicated that the J chain does not bind
directly to SC (2). Studies of cleaved human secretory IgA
indicated that J chain and SC are bound to different frag-
ments of the ot heavy chain and are not disulfide linked
(27). Other studies have shown that SC forms disulfide
bridges only with IgA and not with the J chain (28) . Our
studies revealed that MDCK cells transfected with pIgR
were able to selectively transport Jch"+ mouse-derived
IgA but not Jch-'- mouse-derived IgA. These data are
consistent with the model that the J chain is necessary for
the binding of pIgR to pIgR. One possibility is that the
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presence of the J chain in dimeric IgA influences the con-
formation ofthe ct heavy chain domains and allows binding
to pIgR and SC. Alternatively, J chain-deficient dimers are
able to bind to pIgRs, but lack of the J chain leads to im-
pairment in other aspects of the IgA transcytosis pathway.
The observation that Jch-'- mouse-derived IgA does not
appear to interfere with Jch"+ mouse-derived IgA trans-
port by pIgR+ MDCK cells (data not shown) argues, how-
ever, against this possibility. Ofinterest, unlike bile and fe-
cal IgA levels, IgA levels are not depressed in other
secretions in Jch-1- mice (Hendrickson, B. A., unpub-
lished results). The role of pIgR in J chain-deficient IgA
transport into these secretions is under investigation.
The pIgR transports dimeric IgA but not monomeric
IgA (2, 7). Although Jch-'- mice have lower serum IgA
dimer/monomer ratios than Jch+/' mice, comparable
amounts of serum dimer are present and presumably avail-
able for transport in Jch-/- mice. Hence, deficiency of se-
rum IgA dimer is an unlikely explanation for the low bile
IgA levels in Jch- /- mice. Instead, an inability of hepatic
pIgRs to transport ,the J chain-deficient dimer appears to
be the preferable explanation for the hepatic IgA transport
defect in Jch- /- mice. Numerous studies have shown the
importance of pIgR in the transport of bloodstream-de-
rived pIgR into bile (15, 26). Although the asialoglycopro-
tein receptor has also been implicated in serum IgA clear-
ance, IgA internalized by this mechanism appears to be
primarily targeted for lysosomal degradation (29, 30) . Some
evidence exists for IgA binding by hepatocytes, which ap-
pears to be unrelated to pIgRs or asialoglycoprotein recep-
tors; however, these other putative receptors have not been
ascribed a role in IgA transport into bile (7, 31) . Thus ex-
amination of pIgR+ MDCK cell transport of Jch-'-
mouse-derived IgA is a relevant model for hepatic IgA
transport in Jch-/- mice. This experimental system should
be useful in delineating the steps that are impaired in pIgR
transport ofJ chain-deficient IgA.
Jch-/- mice will be valuable tools in elucidating the
mechanism of IgA dimer stabilization by the J chain and in
the study of the IgA transport mechanisms in the liver and
mucosal epithelium. In addition, IgA secretion into bile has
been proposed to play a role in the immune protection of
the biliary and upper gastrointestinal tracts and in the clear-
ance of detrimental IgA-antigen complexes from the blood-
stream (15). Jch -1- mice may provide a useful model for
examining the relative importance of the biliary IgA secre-
tory pathway in these processes.
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